Microneedle Technology: Lifting The Cross-Interface Veil Of Biomedical Engineering

Microneedle Technology: Lifting the Cross-Interface Veil of Biomedical Engineering

At the forefront of biomedical engineering, pharmaceutics, and materials science, microneedle (MN) technology is revolutionizing transdermal delivery and diagnostic paradigms at an unprecedented pace. By ingeniously merging the efficacy of conventional hypodermic injection with the convenience of transdermal patches, it forges a novel technological path for safely, painlessly, and precisely traversing the skin barrier to achieve controlled substance delivery and bioinformation acquisition.

Figure 1. Schematic of a microneedle array [1]

I. Research Background: The Engineering Imperative to Breach the Barrier

The skin, as the body's largest organ, features the stratum corneum as its outermost defensive shield. While this "percutaneous absorption barrier" effectively repels external threats, it simultaneously impedes the efficient transdermal uptake of most therapeutic macromolecules (e.g., proteins, nucleic acids, vaccines) and hydrophilic drugs. Existing solutions present distinct limitations:

Transdermal Patches:​ Their permeability is constrained by lipophilicity and molecular weight, rendering them ineffective for most large-molecule drugs.

Hypodermic Injection:​ Despite high delivery efficiency, significant drawbacks remain: pain and psychological aversion lead to poor compliance (especially in children and chronic patients); professional administration limits applicability in home-care or resource-limited settings; sharps waste generation increases disposal costs and environmental risks; and there is a potential for neurovascular injury.

Oral Delivery:​ Faces challenges including first-pass hepatic metabolism, gastrointestinal degradation, and high inter-individual variability in absorption.

Microneedle technology was conceived to address this core engineering challenge: how to design an intelligent interface capable of minimally invasive, painless, and on-demand reversible disruption of the stratum corneum to achieve efficient, controlled transdermal transport.

II. Classification: The Spectrum of Structure, Function, and Materials

Microneedles can be classified multidimensionally based on their mechanism, structure, and material composition, each dictating the system's performance boundaries.

1. Classification by Structure and Mechanism

Solid MNs:​ These do not contain drug; they act as physical pre-treatment tools to create microchannels in the skin, followed by passive diffusion of topically applied formulations. Advantages include broad material choice and simple fabrication; disadvantages include a two-step process and reduced convenience.

Coated MNs:​ Drug coatings are applied to the surface of solid microneedles, dissolving upon insertion to release the payload. Suitable for low-dose, readily soluble vaccines or drugs. The challenge lies in limited payload capacity and the long-term storage stability of the coating.

Hollow MNs:​ Mimicking miniature injectors with an internal lumen, they actively infuse liquid drugs via external pressure or capillary action. Ideal for scenarios requiring precise control over infusion rate and dose. However, they face challenges in structural complexity, high manufacturing costs, clogging risks, and stringent mechanical strength requirements.

Dissolving MNs:​ The most promising category. Drugs are homogenously dispersed or encapsulated within a biodegradable/hydro-soluble polymer matrix (e.g., Hyaluronic Acid, Gelatin, PLGA). Upon insertion, the needle body dissolves synchronously with drug release. They offer painlessness, high drug loading, good biocompatibility, and leave no sharps waste. Their core challenge lies in balancing the inherent conflict between mechanical strength and dissolution rate.

Hydrogel-Forming MNs:​ Fabricated from lightly cross-linked hydrophilic polymers. They rapidly swell upon absorbing interstitial fluid to form a gel, enabling sustained drug release via diffusion or polymer degradation. The design difficulty resides in ensuring sufficient puncture stiffness prior to swelling.

Figure 2. Classification of microneedles [2]

2. Classification by Material

Materials form the performance cornerstone, primarily including silicon-based, metallic, polymeric, ceramic, and sugar-based microneedles. The material choice profoundly influences mechanical properties, biocompatibility, drug loading modalities, degradation behavior, and scalability costs.

III. Fabrication: Precision Manufacturing at the Micro/Nano Scale

The scalable, high-precision fabrication of microneedle arrays is the core technology for their practical application, relying heavily on micro/nano-processing and advanced manufacturing techniques.

MEMS Technology:​ Utilizing photolithography combined with dry/wet etching to achieve ultra-high precision and complex 3D structures on hard substrates like silicon and metal. However, equipment and process costs are high.

Micromolding:​ The dominant method for polymer (especially dissolving) microneedles. It involves creating a master template with micro-cavities via techniques like lithography, laser machining, or 3D printing, followed by casting polymer solutions/melts into the template. After curing and demolding, the array is obtained. This method offers high efficiency, controlled costs, and is easily scalable.

Figure 3. Micromolding fabrication of microneedles [3]

Laser Machining:​ Employing femtosecond or CO₂ lasers for direct-write ablation or engraving. This offers high flexibility and is suitable for rapid prototyping or customized designs.

Figure 4. Femtosecond laser fabrication of microneedle arrays [4]

Additive Manufacturing:​ 3D printing technologies like Stereolithography (SLA) or Two-Photon Polymerization (TPP) enable complex internal and external architectures unattainable by conventional methods, providing novel tools for personalized medicine.

Figure 5. 3D printed microneedles [5]

Other Techniques:​ Hot pulling for glass/polymer capillary hollow needles; Electrochemical deposition for metal MNs or as reinforcing layers for polymer MNs.

IV. Applications: Platform Expansion from Therapeutics to Diagnostics

Microneedle technology is permeating critical domains of biomedicine with its unique advantages:

Revolutionary Drug Delivery:​ Provides a painless alternative for large-molecule drugs (insulin, monoclonal antibodies, vaccines, nucleic acids); enables localized or systemic controlled release of small molecules; and acts as an enhancer to boost the absorption efficiency of traditional transdermal preparations.

Next-Generation Vaccine Delivery:​ Painless vaccination significantly improves compliance, especially for children and mass immunization campaigns; targeting the skin's rich immune cell population can elicit stronger, broader immune responses, potentially enabling dose sparing; its simplicity facilitates rapid deployment during public health emergencies.

Minimally Invasive Diagnostics & Continuous Monitoring:​ Enables near-invisible sampling of skin interstitial fluid for glucose monitoring, therapeutic drug monitoring, and biomarker detection; integration with miniature sensors allows for the development of real-time, continuous monitoring patches (e.g., CGM); also applicable for intradermal diagnostic tests.

Precision Medical Aesthetics & Repair:​ Efficiently delivers active cosmetic ingredients (e.g., Vitamin C, Hyaluronic Acid) to the dermis; controlled micro-injuries stimulate the skin's self-repair mechanisms, inducing collagen neogenesis to improve wrinkles, scars, and skin texture; promotes drug penetration and follicular stimulation in alopecia treatment.

Frontier Explorations:​ Includes the development of "smart" delivery systems responsive to specific biological signals; applications in tissue engineering and regenerative medicine for cell and growth factor delivery; and serving as a minimally invasive sampling tool for cosmetic efficacy evaluation.

Figure 6. Applications of microneedles [6]

V. Conclusion and Future Perspectives

As a disruptive platform technology, microneedles are redefining the boundaries of drug delivery, disease diagnostics, and health management. Their core value lies in the intelligent modulation of the biointerface in a minimally invasive, painless, and user-friendly manner.

Looking ahead, with the continuous breakthroughs in materials science and micro/nano-fabrication, microneedle systems will evolve toward higher levels of functional integration (e.g., theranostics), more precise spatiotemporal control (e.g., on-demand release), and broader personalized adaptation. Moving from the laboratory to households worldwide, microneedle technology represents not only the cutting edge of biomedical engineering but also carries the grand vision of realizing accessible, precise, and preventive healthcare.